SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $303,000 | +9.0% | 27,590 | -2.6% | 0.01% | 0.0% |
Q1 2017 | $278,000 | -14.5% | 28,340 | -5.8% | 0.01% | -11.1% |
Q4 2016 | $325,000 | +112.4% | 30,090 | +101.1% | 0.01% | +125.0% |
Q3 2016 | $153,000 | -22.3% | 14,960 | -0.7% | 0.00% | -33.3% |
Q2 2016 | $197,000 | – | 15,070 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sensato Investors LLC | 1,552,482 | $13,755,000 | 2.96% |
Nantahala Capital Management | 1,522,625 | $13,490,000 | 2.24% |
GLOBEFLEX CAPITAL L P | 150,138 | $1,330,000 | 0.25% |
Ativo Capital Management LLC | 71,563 | $634,000 | 0.25% |
MCKINLEY CAPITAL MANAGEMENT LLC | 543,110 | $4,812,000 | 0.19% |
RFG Advisory, LLC | 24,700 | $208,000 | 0.16% |
GSA CAPITAL PARTNERS LLP | 345,833 | $3,064,000 | 0.12% |
Spark Investment Management LLC | 95,900 | $849,000 | 0.12% |
Numeric Investors LLC | 1,002,814 | $8,885,000 | 0.11% |
ClariVest Asset Management LLC | 384,222 | $3,404,000 | 0.10% |